Showing results (151-160 of 326) with videos related to

Sort By:
Pageof 33
Pharmacogenomics|October 27, 2011
Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adultsSilke Hartleb, Ursula Plöckinger, Günter K Stalla, et al.
European Journal of Endocrinology|February 1, 1994
Octreotide exerts different effects in vivo and in vitro in Cushing's diseaseG K Stalla, S J Brockmeier, U Renner, et al.
Endocrinology|February 2, 1999
Inhibition of Zac1, a new gene differentially expressed in the anterior pituitary, increases cell proliferationU Pagotto, T Arzberger, E Ciani, et al.
Neuroendocrinology|July 28, 2001
Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitroP Lohrer, J Gloddek, U Hopfner, et al.
Endocrinology|December 1, 1995
Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxinM Paez Pereda, J Sauer, C Perez Castro, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Suppression of vagus-mediated pancreatic polypeptide release by the mu-opiate receptor agonist loperamide in manR L Riepl, B Reichardt, C J Auernhammer, et al.
Endocrinology|September 20, 2002
Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cellsU Renner, P Lohrer, L Schaaf, et al.
The Journal of Endocrinology|October 27, 2006
Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumoursChiara Onofri, Marily Theodoropoulou, Marco Losa, et al.
Psychiatry Research|July 31, 2013
No acute suppression of cerebrospinal fluid corticotropin-releasing hormone in man by cortisol administrationMichael Kellner, Cornelie Salzwedel, Viola Wortmann, et al.
European Journal of Endocrinology|June 8, 2012
Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomasA P Athanasoulia, C Sievers, M Ising, et al.
Pageof 33